Presently, the MMP-14 blocking antibody DX-2400 has been tested in a murine model of breast cancer, where it inhibited primary tumor growth when administered alone and further impaired the growth when combined with radiotherapy (35). This evidence concerns the gene MMP14 and neoplasm.